详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Lu, You[1,2,3,4,5,6,7,8,9,10,11,12,13] * ; Huang, Meijuan[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Fan, Qingxia[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Wu, Qi[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Wang, Jin[1,2,3,4,5,6,7,8,9,10,11,12,13]

; Li, Lu[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhang, Xi[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Guo, Chengye[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Li, Wenhui[1,2,3,4,5,6,7,8,9,10,11,12,13]

; Peng, Feng[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Ouyang, Xuenong[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Yu, Ding[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Cai, Xiaohong[1,2,3,4,5,6,7,8,9,10,11,12,13]

; Xu, Yong[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Hou, Mei[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Luo, Rongcheng[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhang, Tao[1,2,3,4,5,6,7,8,9,10,11,12,13]

;

机构： [1]Department of Thoracic Oncology, State Key Laboratory of Biotherapy, Huaxi Hospital, Sichuan University, Chengdu, China [2]Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China [3]The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [4]Sichuan Provincial People’s Hospital, Chengdu, China [5]Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan Universitity, Chengdu, China [6]The Third People's Hospital of Chengdu, Chengdu, China [7]Qingdao Municipal Hospital, Qingdao, China [8]Yunnan Cancer Hospital, Kunming, China [9]Fuzhou General Hospital of Nanjing Military Command, Fuzhou, China [10]Hubei Cancer Hospital, Wuhan, China [11]Sichuan Cancer Hospital, Chengdu, China [12]Guangzhou Nanfang Hospital, Guangzhou, China [13]Chengdu Military General Hospital, Chengdu, China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2012]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2012]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Thoracic Oncology, State Key Laboratory of Biotherapy, Huaxi Hospital, Sichuan University, Chengdu, China [2]Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China [3]The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [4]Sichuan Provincial People’s Hospital, Chengdu, China [5]Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan Universitity, Chengdu, China [6]The Third People's Hospital of Chengdu, Chengdu, China [7]Qingdao Municipal Hospital, Qingdao, China [8]Yunnan Cancer Hospital, Kunming, China [9]Fuzhou General Hospital of Nanjing Military Command, Fuzhou, China [10]Hubei Cancer Hospital, Wuhan, China [11]Sichuan Cancer Hospital, Chengdu, China [12]Guangzhou Nanfang Hospital, Guangzhou, China [13]Chengdu Military General Hospital, Chengdu, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Endostar plus gemcitabine/cisplatin (GP) with maintenance endostar as first-line therapy for advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study

文献详情